Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
Main Authors: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
BioMed Central
2016
|
פריטים דומים
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
מאת: Saunders, K, et al.
יצא לאור: (2016) -
Older patients are eligible for trial of lithium and valproate.
מאת: Rendell, J, et al.
יצא לאור: (2003) -
New trial should clarify lithium use in bipolar disorder.
מאת: Geddes, J, et al.
יצא לאור: (2002) -
Lith6
מאת: Malcolm A. Lyons, et al.
יצא לאור: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
מאת: Atkinson, L, et al.
יצא לאור: (2019)